Astria Therapeutics Inc | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Astria Therapeutics Inc | 10-Q: Q2 2024 Earnings Report
Astria Therapeutics Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(12.193%),Abigail P. Johnson(12.193%)
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Director LAPOINTE ANTHONY GREGG
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Director Beck Joanne T.
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Director Violin Jonathan
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Director Callori Fred
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Director Cole Hugh M
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Director KISHBAUCH MICHAEL D
Astria Therapeutics Inc | 8-K: Current report
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Director BATE KENNETH
Astria Therapeutics Inc | 10-Q: Q1 2024 Earnings Report
Astria Therapeutics Inc | DEFA14A: Others
Astria Therapeutics Inc | ARS: Annual Report to Security Holders
Astria Therapeutics Inc | DEF 14A: Definitive information statements
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Director AGARWAL SUNIL
Astria Therapeutics Inc | 3: Initial statement of beneficial ownership of securities-Director AGARWAL SUNIL
Astria Therapeutics Inc | 8-K: Current report
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Officer Morabito Christopher
Astria Therapeutics Inc | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data